Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


11.12.2017

6 Am J Hematol
1 Ann Hematol
1 Blood
3 Br J Haematol
5 Cancer
1 Cancer Chemother Pharmacol
1 Cancer Lett
1 J Clin Oncol
9 J Pediatr Hematol Oncol
6 Leuk Lymphoma
13 Leukemia


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. DINARDO CD, Rausch CR, Benton C, Kadia T, et al
    Clinical Experience with the BCL2-inhibitor Venetoclax in Combination Therapy for Relapsed and Refractory Acute Myeloid Leukemia and Related Myeloid Malignancies.
    Am J Hematol. 2017 Dec 8. doi: 10.1002/ajh.25000.
    PubMed     Text format     Abstract available

  2. COLTRO G, Mannelli F, Guglielmelli P, Pacilli A, et al
    A life-threatening ruxolitinib discontinuation syndrome.
    Am J Hematol. 2017;92:833-838.
    PubMed     Text format    

  3. YSEBAERT L, Aurran-Schleinitz T, Dartigeas C, Dilhuydy MS, et al
    Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.
    Am J Hematol. 2017;92:E166-E168.
    PubMed     Text format    

  4. MOLICA S, Giannarelli D, Mirabelli R, Levato L, et al
    Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase.
    Am J Hematol. 2017;92:E91-E93.
    PubMed     Text format    

  5. DE ROCCO D, Melazzini F, Marconi C, Pecci A, et al
    Mutations of RUNX1 in families with inherited thrombocytopenia.
    Am J Hematol. 2017;92:E86-E88.
    PubMed     Text format    

  6. DINARDO CD, Luskin MR, Carroll M, Smith C, et al
    Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AML.
    Am J Hematol. 2017;92:E14-E15.
    PubMed     Text format    


    Ann Hematol

  7. HARADA K, Doki N, Hagino T, Miyawaki S, et al
    Underweight status at diagnosis is associated with poorer outcomes in adult patients with acute myeloid leukemia: a retrospective study of JALSG AML 201.
    Ann Hematol. 2017 Dec 2. pii: 10.1007/s00277-017-3156.
    PubMed     Text format     Abstract available


    Blood

  8. STEIN EM, Walter RB, Erba HP, Fathi AT, et al
    A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33 positive acute myeloid leukemia (AML).
    Blood. 2017 Dec 1. pii: blood-2017-06-789800. doi: 10.1182/blood-2017-06-789800.
    PubMed     Text format     Abstract available


    Br J Haematol

  9. WOLACH O, Amitai I, DeAngelo DJ
    Current challenges and opportunities in treating adult patients with Philadelphia-negative acute lymphoblastic leukaemia.
    Br J Haematol. 2017;179:705-723.
    PubMed     Text format     Abstract available

  10. PAVIGLIANITI A, Ruggeri A, Volt F, Sanz G, et al
    Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.
    Br J Haematol. 2017;179:790-801.
    PubMed     Text format     Abstract available

  11. KHARFAN-DABAJA MA, Al Malki MM, Deotare U, Raj RV, et al
    Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
    Br J Haematol. 2017;179:781-789.
    PubMed     Text format     Abstract available


    Cancer

  12. NEUKIRCHEN J, Lauseker M, Hildebrandt B, Nolting AC, et al
    Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.
    Cancer. 2017;123:4608-4616.
    PubMed     Text format     Abstract available

  13. HOWELL CR, Wilson CL, Ehrhardt MJ, Partin RE, et al
    Clinical impact of sedentary behaviors in adult survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort study.
    Cancer. 2017 Dec 4. doi: 10.1002/cncr.31162.
    PubMed     Text format     Abstract available

  14. TAI EW, Ward KC, Bonaventure A, Siegel DA, et al
    Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5178-5189.
    PubMed     Text format     Abstract available

  15. SCHIFFER CA
    "Epigenetic" modification as therapy for acute myeloid leukemia.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31137.
    PubMed     Text format    

  16. ROBOZ GJ, Kantarjian HM, Yee KWL, Kropf PL, et al
    Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31138.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  17. VOLLER S, Pichlmeier U, Zens A, Hempel G, et al
    Pharmacokinetics of recombinant asparaginase in children with acute lymphoblastic leukemia.
    Cancer Chemother Pharmacol. 2017 Dec 5. pii: 10.1007/s00280-017-3492.
    PubMed     Text format     Abstract available


    Cancer Lett

  18. DE COLA A, Franceschini M, Di Matteo A, Colotti G, et al
    N6L pseudopeptide interferes with nucleophosmin protein-protein interactions and sensitizes leukemic cells to chemotherapy.
    Cancer Lett. 2018;412:272-282.
    PubMed     Text format     Abstract available


    J Clin Oncol

  19. SHAH NP
    Front-Line Treatment Options for Chronic-Phase Chronic Myeloid Leukemia.
    J Clin Oncol. 2017 Dec 5:JCO2017754663. doi: 10.1200/JCO.2017.75.4663.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  20. BANERJEE JS, Heyman M, Palomaki M, Lahteenmaki P, et al
    Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001009.
    PubMed     Text format     Abstract available

  21. VALLIYAMMAI N, Nancy NK, Sagar TG, Rajkumar T, et al
    Study of NOTCH1 and FBXW7 Mutations and Its Prognostic Significance in South Indian T-Cell Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001006.
    PubMed     Text format     Abstract available

  22. HONG KT, Choi JY, Hong CR, Kang HJ, et al
    Therapy-related Acute Myeloid Leukemia After the Treatment of Primary Solid Cancer in Children: A Single-center Experience.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001019.
    PubMed     Text format     Abstract available

  23. ABAZA HM, Alfeky MAA, Eissa DS, Abdel Fattah MF, et al
    Neuropilin-1/CD304 Expression by Flow Cytometry in Pediatric Precursor B-Acute Lymphoblastic Leukemia: A Minimal Residual Disease and Potential Prognostic Marker.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001008.
    PubMed     Text format     Abstract available

  24. WANG YM, Nudleman E, Vinocur D, Kuo DJ, et al
    Terson Syndrome Before Induction Chemotherapy for Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001047.
    PubMed     Text format     Abstract available

  25. BERGER-ACHITUV S, Elhasid R
    Reduced Neutrophil Elastase Activity and Neutrophil Extracellular Traps in Pediatric Acute Myeloid Leukemia May Increase the Rate of Infections.
    J Pediatr Hematol Oncol. 2017 Dec 1. doi: 10.1097/MPH.0000000000001015.
    PubMed     Text format     Abstract available

  26. TSUJIMOTO SI, Nakano Y, Osumi T, Okada K, et al
    A Cryptic NUP214-ABL1 Fusion in B-cell Precursor Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 6. doi: 10.1097/MPH.0000000000001007.
    PubMed     Text format     Abstract available

  27. DE LEONARDIS F, Koronica R, Daniele RM, Santoro N, et al
    Thrombotic Thrombocytopenic Purpura in a Child Treated for Acute Lymphoblastic Leukemia: Case Report and Review of Literature.
    J Pediatr Hematol Oncol. 2017 Dec 6. doi: 10.1097/MPH.0000000000001050.
    PubMed     Text format     Abstract available

  28. PEKPAK E, Ileri T, Ince E, Ertem M, et al
    Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 6. doi: 10.1097/MPH.0000000000001022.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  29. LEI H, Wang W, Wu Y
    Targeting oncoproteins for degradation by small molecules in myeloid leukemia.
    Leuk Lymphoma. 2017 Dec 4:1-8. doi: 10.1080/10428194.2017.1403600.
    PubMed     Text format     Abstract available

  30. CHENG WY, Zhu YM, Cheng S, Chen YS, et al
    Development of B-cell prolymphocytic leukemia in a patient with splenic diffuse red pulp small B-cell lymphoma.
    Leuk Lymphoma. 2017 Dec 3:1-4. doi: 10.1080/10428194.2017.1405397.
    PubMed     Text format    

  31. GUPTA SK, Bakhshi S, Chopra A, Kamal VK, et al
    Molecular genetic profile in BCR-ABL1 negative pediatric B-cell acute lymphoblastic leukemia can further refine outcome prediction in addition to that by end-induction minimal residual disease detection.
    Leuk Lymphoma. 2017 Dec 3:1-6. doi: 10.1080/10428194.2017.1408087.
    PubMed     Text format     Abstract available

  32. HERNANDEZ-GONZALEZ O, Ortiz-Zamudio JJ, Rodriguez-Pinal CJ, Alvarado-Morales I, et al
    Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.
    Leuk Lymphoma. 2017 Dec 7:1-8. doi: 10.1080/10428194.2017.1406090.
    PubMed     Text format     Abstract available

  33. LI H, Zhang W, Kuang P, Ye Y, et al
    Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients.
    Leuk Lymphoma. 2017 Dec 7:1-9. doi: 10.1080/10428194.2017.1406933.
    PubMed     Text format     Abstract available

  34. HALDER A, Nayak KB, Chakraborty S
    Ecotopic viral integration site 1 (EVI1) transcriptionally targets talin1 (TLN1) and upregulates its expression in chronic myeloid leukemia.
    Leuk Lymphoma. 2017 Dec 7:1-3. doi: 10.1080/10428194.2017.1406089.
    PubMed     Text format    


    Leukemia

  35. HA VL, Luong A, Li F, Casero D, et al
    The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
    Leukemia. 2017;31:2503-2514.
    PubMed     Text format     Abstract available

  36. ABRAHAM M, Klein S, Bulvik B, Wald H, et al
    The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered miR-15a/16-1 expression.
    Leukemia. 2017;31:2336-2346.
    PubMed     Text format     Abstract available

  37. KRAMER AC, Kothari A, Wilson WC, Celik H, et al
    Dnmt3a regulates T-cell development and suppresses T-ALL transformation.
    Leukemia. 2017;31:2479-2490.
    PubMed     Text format     Abstract available

  38. SAVINO AM, Sarno J, Trentin L, Vieri M, et al
    The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.
    Leukemia. 2017;31:2365-2375.
    PubMed     Text format     Abstract available

  39. HOWARD DR, Munir T, McParland L, Rawstron AC, et al
    Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.
    Leukemia. 2017;31:2416-2425.
    PubMed     Text format     Abstract available

  40. O'LEARY HA, Capitano M, Cooper S, Mantel C, et al
    DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms.
    Leukemia. 2017;31:2468-2478.
    PubMed     Text format     Abstract available

  41. THIEL VN, Giaimo BD, Schwarz P, Soller K, et al
    Heterodimerization of AML1/ETO with CBFbeta is required for leukemogenesis but not for myeloproliferation.
    Leukemia. 2017;31:2491-2502.
    PubMed     Text format     Abstract available

  42. LIU X, Rothe K, Yen R, Fruhstorfer C, et al
    A novel AHI-1-BCR-ABL-DNM2 complex regulates leukemic properties of primitive CML cells through enhanced cellular endocytosis and ROS-mediated autophagy.
    Leukemia. 2017;31:2376-2387.
    PubMed     Text format     Abstract available

  43. PULIKKAN JA, Tenen DG, Behre G
    C/EBPalpha deregulation as a paradigm for leukemogenesis.
    Leukemia. 2017;31:2279-2285.
    PubMed     Text format     Abstract available

  44. HADZIJUSUFOVIC E, Albrecht-Schgoer K, Huber K, Hoermann G, et al
    Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target site.
    Leukemia. 2017;31:2388-2397.
    PubMed     Text format     Abstract available

  45. TIRADO-GONZALEZ I, Czlonka E, Nevmerzhitskaya A, Soetopo D, et al
    CRISPR/Cas9 edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC.
    Leukemia. 2017 Dec 6. pii: leu2017346. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  46. DRIESSEN EMC, de Lorenzo P, Campbell M, Felice M, et al
    Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.
    Leukemia. 2017;31:2854.
    PubMed     Text format     Abstract available

  47. DELL'AVERSANA C, Giorgio C, D'Amato L, Lania G, et al
    miR-194-5p/BCLAF1 deregulation in AML tumorigenesis.
    Leukemia. 2017;31:2315-2325.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: